| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/11/2002 | WO2002028837A1 Metabotropic glutamate receptor antagonists |
| 04/11/2002 | WO2002028835A1 Benzamide compounds as apo b secretion inhibitors |
| 04/11/2002 | WO2002028831A1 Inhibitors of prenyl-protein transferase |
| 04/11/2002 | WO2002028830A1 Novel phenylalanine derivatives |
| 04/11/2002 | WO2002028820A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | WO2002028433A2 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 04/11/2002 | WO2002028413A1 Bone health compositions derived from milk |
| 04/11/2002 | WO2002028398A1 Compositions for treating diabetes |
| 04/11/2002 | WO2002028397A1 Diabetes remedies |
| 04/11/2002 | WO2002028396A1 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 04/11/2002 | WO2002028379A2 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 04/11/2002 | WO2002028377A1 Ihnalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | WO2002028374A1 Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same |
| 04/11/2002 | WO2002028347A2 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 04/11/2002 | WO2002028346A2 Association of the cb1 receptor antagonist and sibutramin, for treating obesity |
| 04/11/2002 | WO2002028181A1 Sustained release pharmaceutical compositions containing metformin and method of its production |
| 04/11/2002 | WO2002028165A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | WO2002000725A3 G-protein coupled receptor org10 |
| 04/11/2002 | WO2001092308A3 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 04/11/2002 | WO2001090070A3 Caspase inhibitors and uses thereof |
| 04/11/2002 | WO2001083450A3 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
| 04/11/2002 | WO2001082868A3 A medicinal aerosol formulation |
| 04/11/2002 | WO2001078680A3 Pharmaceutical compositions comprising fluvastatin |
| 04/11/2002 | WO2001076715A3 Method for the fractionation of oil and polar lipid-containing native raw materials |
| 04/11/2002 | WO2001076572A3 Use of compatible solutes as substances having free radical scavenging properties |
| 04/11/2002 | WO2001072688A3 Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof |
| 04/11/2002 | WO2001070989A3 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 04/11/2002 | WO2001066085A3 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 04/11/2002 | WO2001058937A3 Interferon-alpha induced genes |
| 04/11/2002 | WO2001053348A3 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 04/11/2002 | WO2001000185A3 1,4-denzothiazepines to treat obesity related disorders |
| 04/11/2002 | WO2000012493A9 Thiazoline acid derivatives |
| 04/11/2002 | US20020042515 Tetrahydroquinolines |
| 04/11/2002 | US20020042513 Therapeutic compounds |
| 04/11/2002 | US20020042512 Alpha-acyl- and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 04/11/2002 | US20020042505 Novel human ion channel protein and polynucleotides encoding the same |
| 04/11/2002 | US20020042444 Treatment of lipid metabolic disorders using 5-(1,2-dithiolan-3-yl) valeric acid (alpha-lipoic acid) or its physiologically compatible salts |
| 04/11/2002 | US20020042443 Estrogen agonist / antagonist metabolites |
| 04/11/2002 | US20020042441 N-substituted indoles useful in the treatment of diabetes |
| 04/11/2002 | US20020042434 Pharmaceutical composition |
| 04/11/2002 | US20020042421 Antiinflammatory agents |
| 04/11/2002 | US20020042415 Dipeptide derivatives |
| 04/11/2002 | US20020042405 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure |
| 04/11/2002 | US20020042400 Antihistamines |
| 04/11/2002 | US20020042395 Method of treating high plasma cholesterol levels |
| 04/11/2002 | US20020042385 Cloning of a novel 7TM receptor AXOR-2 |
| 04/11/2002 | US20020042381 Antilipemic agents |
| 04/11/2002 | US20020042376 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 04/11/2002 | US20020042368 Integrin antagonists |
| 04/11/2002 | US20020042364 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 04/11/2002 | US20020042359 Regulators of PPARdelta (beta) and their use in the treatment of obesity and insulin resistance |
| 04/11/2002 | US20020042357 Polypharmacophoric agents |
| 04/11/2002 | US20020042091 Methods and compositions for screening modulators of lipid kinases |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2425185A1 Benzimidazole and indole derivatives as crf receptor modulators |
| 04/11/2002 | CA2425152A1 Highly expressible genes |
| 04/11/2002 | CA2425126A1 Lipid metabolism enzymes |
| 04/11/2002 | CA2425097A1 Benzamide compounds as apo b secretion inhibitors |
| 04/11/2002 | CA2424981A1 Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same |
| 04/11/2002 | CA2424934A1 Association of the cb1 receptor antagonist and sibutramin, for treating obesity |
| 04/11/2002 | CA2424880A1 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | CA2424620A1 Inhalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | CA2424604A1 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | CA2424581A1 Compounds useful for treating hypertriglyceridemia |
| 04/11/2002 | CA2424222A1 Inhibitors of prenyl-protein transferase |
| 04/11/2002 | CA2424216A1 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
| 04/11/2002 | CA2423888A1 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | CA2423462A1 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | CA2421782A1 Quinoline and quinolinone derivatives as metabotropic glutamate receptor antagonists |
| 04/10/2002 | EP1195605A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195604A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195371A1 Process for the preparation of tricyclic amino alcohol derivatives |
| 04/10/2002 | EP1195164A1 Remedies for drug-resistant hypercalcemia |
| 04/10/2002 | EP1194777A1 Methods and compositions relating to pancreatic islet and beta-cell dysfunction |
| 04/10/2002 | EP1194595A1 Polymorphisms in the human hmg-coa reductase gene |
| 04/10/2002 | EP1194584A1 Method for producing oligopolysaccharides |
| 04/10/2002 | EP1194557A2 An interleukin-1 receptor antagonist and uses thereof |
| 04/10/2002 | EP1194546A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 04/10/2002 | EP1194543A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 04/10/2002 | EP1194443A1 Cysteinyl protease inhibitors |
| 04/10/2002 | EP1194439A1 Human eag2 |
| 04/10/2002 | EP1194430A1 Novel process |
| 04/10/2002 | EP1194422A1 Biaryl compounds |
| 04/10/2002 | EP1194421A1 Selective npy (y5) antagonists |
| 04/10/2002 | EP1194411A1 Benzoylpyridazines |
| 04/10/2002 | EP1194409A1 Pyrazolidinol compounds |
| 04/10/2002 | EP1194172A1 Compositions and methods for the treatment or prevention of autoimmune disorders |
| 04/10/2002 | EP1194168A2 Methods and products for manipulating uncoupling protein expression |
| 04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 04/10/2002 | EP1194159A1 Use of interleukin-6 in treatment of obesity and/or obesity associated disorders |
| 04/10/2002 | EP1194157A1 D-form polypeptide which induces immune tolerance and methods of use |
| 04/10/2002 | EP1194147A1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 04/10/2002 | EP1194146A1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 04/10/2002 | EP1194140A1 Pharmaceutical composition containing fenofibrate and preparation method |
| 04/10/2002 | EP1194138A1 Nutritional supplements |
| 04/10/2002 | EP1194044A1 Novel pharmaceutical or dietetic mushroom-based compositions |